WHERE DO WE STAND WITH PRIMARY TREATMENT OF BREAST CANCER

被引:0
|
作者
SPRATT, JS
机构
[1] CANC RES CTR,BUSINESS LOOP 70 & GARTH AVE,COLUMBIA,MO 65201
[2] ELLIS FISCHEL STATE CANC HOSP,COLUMBIA,MO 65201
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:676 / 678
页数:3
相关论文
共 50 条
  • [21] Where do we stand with IPF treatment?
    C Albera
    C Ferrero
    E Rindone
    S Zanotto
    E Rizza
    Respiratory Research, 14
  • [22] Prolonged anticoagulant treatment in patients with cancer: Where do we stand?
    Napolitano, Mariasanta
    Siragusa, Sergio
    THROMBOSIS RESEARCH, 2017, 158 : 152 - 153
  • [23] Breast tomosynthesis: What do we know and where do we stand?
    Mandoul, C.
    Verheyden, C.
    Millet, I
    Orliac, C.
    Pages, E.
    Thomassin, I
    Taourel, P.
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2019, 100 (10) : 537 - 551
  • [24] Breast units in Europe - where do we stand?
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 181 - 181
  • [25] Primary Immunodeficiency Disorders: Where Do We Stand?
    Anju Gupta
    The Indian Journal of Pediatrics, 2019, 86 : 873 - 874
  • [26] Primary Immunodeficiency Disorders: Where Do We Stand?
    Gupta, Anju
    INDIAN JOURNAL OF PEDIATRICS, 2019, 86 (10): : 873 - 874
  • [27] Where do we stand in advanced breast ultrasound?
    Mundinger, Alexander
    Wilson, A. R. M.
    Weismann, C.
    Rizzatto, G.
    Mendelson, E. B.
    Madjar, H.
    Durante, E.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S15 - S17
  • [28] Prediction of breast cancer metastasis by genomic profiling: where do we stand?
    Pfeffer, Ulrich
    Romeo, Francesco
    Noonan, Douglas M.
    Albini, Adriana
    CLINICAL & EXPERIMENTAL METASTASIS, 2009, 26 (06) : 547 - 558
  • [29] Prevention of ER-negative breast cancer: where do we stand?
    Cazzaniga, Massimiliano
    Bonanni, Bernardo
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2012, 21 (02) : 171 - 181
  • [30] Breast Cancer Prevention by Antihormones and Other Drugs Where Do We Stand?
    Lazzeroni, Matteo
    DeCensi, Andrea
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2013, 27 (04) : 657 - +